Roflumilast and the Changing Landscape of Seborrheic Dermatitis Treatment
{{output}}
Objective: This article reviews clinical trial data that assess the safety, efficacy, and clinical application of roflumilast, a phosphodiesterase-4 inhibitor, for the treatment of seborrheic dermatitis. ... ...
